BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006;13:668-676. [PMID: 16523369 DOI: 10.1245/aso.2006.05.039] [Cited by in Crossref: 255] [Cited by in F6Publishing: 93] [Article Influence: 15.9] [Reference Citation Analysis]
Number Citing Articles
1 Ko S, Kirihataya Y, Matsusaka M, Mukogawa T, Ishikawa H, Watanabe A. Parenchyma-Sparing Hepatectomy with Vascular Reconstruction Techniques for Resection of Colorectal Liver Metastases with Major Vascular Invasion. Ann Surg Oncol 2016;23:501-7. [PMID: 27401445 DOI: 10.1245/s10434-016-5378-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
2 Lim TZ, Chan DKH, Tan KK. Endoscopic stenting should be advocated in patients with stage IV colorectal cancer presenting with acute obstruction. J Gastrointest Oncol 2018;9:785-90. [PMID: 30505576 DOI: 10.21037/jgo.2018.06.03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Scorsetti M, Comito T, Clerici E, Franzese C, Tozzi A, Iftode C, Di Brina L, Navarria P, Mancosu P, Reggiori G, Fogliata A, Tomatis S, Torzilli G, Cozzi L. Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up. Radiat Oncol 2018;13:234. [PMID: 30477560 DOI: 10.1186/s13014-018-1185-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
4 Watanabe Y, Tamagawa H, Mizushima T, Taniguchi E, Kikkawa H, Sasaki M, Nakaba H. Colon liver metastasis complicated with tumor thrombus in the bile duct: A case report. Int J Surg Case Rep 2018;49:235-8. [PMID: 30056347 DOI: 10.1016/j.ijscr.2018.06.040] [Reference Citation Analysis]
5 Huang H, Zhang L, Chen DB, Yu XG, He XH, Liu M, Chen PS. Validation of Prognosis Value of Cumulative Prognostic Scores Based on Serum High-Density Lipoprotein Cholesterol and Albumin Levels in Patients with Colorectal Cancer. J Cancer 2019;10:35-42. [PMID: 30662523 DOI: 10.7150/jca.26637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Nakanishi W, Miyagi S, Tokodai K, Fujio A, Sasaki K, Shono Y, Unno M, Kamei T. Effect of enhanced recovery after surgery protocol on recovery after open hepatectomy: a randomized clinical trial. Ann Surg Treat Res 2020;99:320-8. [PMID: 33304859 DOI: 10.4174/astr.2020.99.6.320] [Reference Citation Analysis]
7 Bashir MR. Patient Triage for Resection of Metastatic Colorectal Cancer to the Liver: Can We Do Better Using MRI? Radiology 2020;297:595-6. [PMID: 33026289 DOI: 10.1148/radiol.2020203631] [Reference Citation Analysis]
8 Fu J, Jiang M, Tan Y, Yang J, Wu L, Feng L, Zheng S, Yuan Y. Synchronous Resectable Metastatic Colorectal Cancer: Lymph Node Involvement Predicts Poor Outcome. Medicine (Baltimore) 2015;94:e1215. [PMID: 26222850 DOI: 10.1097/MD.0000000000001215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
9 Gomez D, Morris-Stiff G, Toogood GJ, Lodge JP, Prasad KR. Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases. HPB (Oxford) 2010;12:84-93. [PMID: 20495651 DOI: 10.1111/j.1477-2574.2009.00127.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
10 Jin KM, Wang K, Bao Q, Wang HW, Xing BC. Liver resection for colorectal liver-limited metastases in elderly patients: a propensity score matching analysis. World J Surg Oncol 2020;18:275. [PMID: 33099304 DOI: 10.1186/s12957-020-02055-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 O'Sullivan S, Cagney DN. The emerging role of stereotactic radiotherapy in gastrointestinal malignancies: a review of the literature and analysis from the Irish perspective. Ir J Med Sci 2018;187:887-94. [PMID: 29423821 DOI: 10.1007/s11845-018-1755-8] [Reference Citation Analysis]
12 Hamilton TD, Leugner D, Kopciuk K, Dixon E, Sutherland FR, Bathe OF. Identification of prognostic inflammatory factors in colorectal liver metastases. BMC Cancer. 2014;14:542. [PMID: 25069793 DOI: 10.1186/1471-2407-14-542] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
13 Ito T, Sugiura T, Okamura Y, Yamamoto Y, Ashida R, Ohgi K, Yasui H, Yamazaki K, Uesaka K. The Safety and Survival Outcome of Hepatectomy with Combined Bile Duct Resection for Colorectal Liver Metastasis. World J Surg 2020;44:1231-43. [PMID: 31832703 DOI: 10.1007/s00268-019-05326-y] [Reference Citation Analysis]
14 Dunne EM, Fraser IM, Liu M. Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions. Ann Transl Med 2018;6:283. [PMID: 30105233 DOI: 10.21037/atm.2018.06.40] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
15 Lipshitz J, Astrow AB, Xu Y. A unique and as yet unexplored subset of metastatic colorectal cancer: widespread lymph-node-only recurrence. J Gastrointest Cancer 2013;44:466-71. [PMID: 23247989 DOI: 10.1007/s12029-012-9470-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Kron P, Kimura N, Farid S, Lodge JPA. Current role of trisectionectomy for hepatopancreatobiliary malignancies. Ann Gastroenterol Surg 2019;3:606-19. [PMID: 31788649 DOI: 10.1002/ags3.12292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Giustiniano E, Nisi F, Rocchi L, Zito PC, Ruggieri N, Cimino MM, Torzilli G, Cecconi M. Perioperative Management of Complex Hepatectomy for Colorectal Liver Metastases: The Alliance between the Surgeon and the Anesthetist. Cancers (Basel) 2021;13:2203. [PMID: 34063684 DOI: 10.3390/cancers13092203] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lim TZ, Tan KK. Endoscopic stenting in colorectal cancer. J Gastrointest Oncol 2019;10:1171-82. [PMID: 31949937 DOI: 10.21037/jgo.2019.02.15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Brown KGM, Koh CE. Surgical management of recurrent colon cancer. J Gastrointest Oncol 2020;11:513-25. [PMID: 32655930 DOI: 10.21037/jgo-2019-ccm-09] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Herrmann E, Terribilini D, Manser P, Fix MK, Toporek G, Candinas D, Weber S, Aebersold DM, Loessl K. Accuracy assessment of a potential clinical use of navigation-guided intra-operative liver metastasis brachytherapy-a planning study. Strahlenther Onkol 2018;194:1030-8. [PMID: 30022277 DOI: 10.1007/s00066-018-1334-y] [Reference Citation Analysis]
21 Desai NB, Laine AM, Timmerman RD. Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.Br J Radiol. 2017;90:20160500. [PMID: 28008774 DOI: 10.1259/bjr.20160500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
22 Handgraaf HJM, Boogerd LSF, Höppener DJ, Peloso A, Sibinga Mulder BG, Hoogstins CES, Hartgrink HH, van de Velde CJH, Mieog JSD, Swijnenburg RJ, Putter H, Maestri M, Braat AE, Frangioni JV, Vahrmeijer AL. Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysis. Eur J Surg Oncol 2017;43:1463-71. [PMID: 28528189 DOI: 10.1016/j.ejso.2017.04.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
23 Song Y, Shannon AB, Roses RE, Fraker DL, Kelz RR, Karakousis GC. National trends in ventral hernia repairs for patients with intra-abdominal metastases. Surgery 2020;168:509-17. [PMID: 32439207 DOI: 10.1016/j.surg.2020.04.005] [Reference Citation Analysis]
24 Hackl C, Neumann P, Gerken M, Loss M, Klinkhammer-Schalke M, Schlitt HJ. Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer. 2014;14:810. [PMID: 25369977 DOI: 10.1186/1471-2407-14-810] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 10.3] [Reference Citation Analysis]
25 Owen JW, Fowler KJ, Doyle MB, Saad NE, Linehan DC, Chapman WC. Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging. HPB (Oxford). 2016;18:296-303. [PMID: 27017170 DOI: 10.1016/j.hpb.2015.10.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
26 Häfner MF, Debus J. Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives. Visc Med 2016;32:172-7. [PMID: 27493944 DOI: 10.1159/000446486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
27 Nozawa H, Tanaka J, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Hata K, Kazama S, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Nakajima J, Kokudo N, Watanabe T. Predictors and outcome of complete removal of colorectal cancer with synchronous lung metastases. Mol Clin Oncol 2015;3:1041-7. [PMID: 26623047 DOI: 10.3892/mco.2015.599] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
28 Skof E, Rebersek M, Hlebanja Z, Ocvirk J. Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial. BMC Cancer 2009;9:120. [PMID: 19386096 DOI: 10.1186/1471-2407-9-120] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
29 Jiang DM, Suzuki C, Espin-Garcia O, Lim CH, Ma LX, Sun P, Sim HW, Natori A, Chan BA, Moignard S, Chen EX, Liu G, Swallow CJ, Darling GE, Wong R, Jang RW, Elimova E. Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma. Cancer Med 2020;9:3023-32. [PMID: 32130793 DOI: 10.1002/cam4.2948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 García-Alfonso P, Ferrer A, Gil S, Dueñas R, Pérez MT, Molina R, Capdevila J, Safont MJ, Castañón C, Cano JM, Lara R. Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents. Target Oncol 2015;10:453-65. [PMID: 25752908 DOI: 10.1007/s11523-015-0362-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
31 Ali MA, Di Sandro S, Lauterio A, Concone G, Mangoni I, Ferla F, Rotiroti V, Cusumano C, Giacomoni A, De Carlis L. Repeat Hepatectomy for Recurrent Colorectal Liver Metastases: Is it Worth the Challenge? J Gastrointest Surg. 2015;19:2192-2198. [PMID: 26361773 DOI: 10.1007/s11605-015-2939-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
32 Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, Alexander DD, Choti MA, Poston G. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283-301. [PMID: 23152705 DOI: 10.2147/clep.s34285] [Cited by in Crossref: 67] [Cited by in F6Publishing: 154] [Article Influence: 6.7] [Reference Citation Analysis]
33 van der Vorst JR, Schaafsma BE, Hutteman M, Verbeek FP, Liefers GJ, Hartgrink HH, Smit VT, Löwik CW, van de Velde CJ, Frangioni JV. Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer. 2013;119:3411-3418. [PMID: 23794086 DOI: 10.1002/cncr.28203] [Cited by in Crossref: 163] [Cited by in F6Publishing: 163] [Article Influence: 18.1] [Reference Citation Analysis]
34 Chan KM, Chiang JM, Lee CF, Yu MC, Lee WC, Chen JS, Wang JY. Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment. World J Surg Oncol 2011;9:174. [PMID: 22208884 DOI: 10.1186/1477-7819-9-174] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
35 Schaafsma BE, Mieog JS, Hutteman M, van der Vorst JR, Kuppen PJ, Löwik CW, Frangioni JV, van de Velde CJ, Vahrmeijer AL. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011;104:323-332. [PMID: 21495033 DOI: 10.1002/jso.21943] [Cited by in Crossref: 481] [Cited by in F6Publishing: 430] [Article Influence: 43.7] [Reference Citation Analysis]
36 Weinrich M, Weiß C, Schuld J, Rau BM. Liver resections of isolated liver metastasis in breast cancer: results and possible prognostic factors. HPB Surg 2014;2014:893829. [PMID: 24550602 DOI: 10.1155/2014/893829] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
37 Angelsen JH, Viste A, Løes IM, Eide GE, Hoem D, Sorbye H, Horn A. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases. World J Surg Oncol 2015;13:328. [PMID: 26631156 DOI: 10.1186/s12957-015-0738-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
38 Rosenberg SA, Henke LE, Shaverdian N, Mittauer K, Wojcieszynski AP, Hullett CR, Kamrava M, Lamb J, Cao M, Green OL, Kashani R, Paliwal B, Bayouth J, Harari PM, Olsen JR, Lee P, Parikh PJ, Bassetti M. A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy. Adv Radiat Oncol 2019;4:142-9. [PMID: 30706022 DOI: 10.1016/j.adro.2018.08.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
39 Khan K, Wale A, Brown G, Chau I. Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone? World J Gastroenterol 2014; 20(35): 12391-12406 [PMID: 25253940 DOI: 10.3748/wjg.v20.i35.12391] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
40 Frühling P, Hellberg K, Ejder P, Strömberg C, Urdzik J, Isaksson B. The prognostic value of C-reactive protein and albumin in patients undergoing resection of colorectal liver metastases. A retrospective cohort study. HPB (Oxford) 2021;23:970-8. [PMID: 33214053 DOI: 10.1016/j.hpb.2020.10.019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Comito T, Clerici E, Tozzi A, D'Agostino G. Liver metastases and SBRT: A new paradigm? Rep Pract Oncol Radiother 2015;20:464-71. [PMID: 26696787 DOI: 10.1016/j.rpor.2014.10.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
42 Lee RC, Kanhere H, Trochsler M, Broadbridge V, Maddern G, Price TJ. Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases? World J Gastrointest Oncol 2018; 10(8): 211-220 [PMID: 30147847 DOI: 10.4251/wjgo.v10.i8.211] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
43 Blesa JM, Canales JL, Soler AA, Monzó FP, Puche JB, Candel VA. Isolated colorectal liver metastases locally progressing after stereotactic body radiotherapy rescued with surgery. Curr Oncol 2009;16:76-80. [PMID: 19862364 DOI: 10.3747/co.v16i5.360] [Reference Citation Analysis]
44 Shaw E, Massaro N, Brockton NT. The role of vitamin D in hepatic metastases from colorectal cancer. Clin Transl Oncol 2018;20:259-73. [PMID: 28801869 DOI: 10.1007/s12094-017-1735-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Spelt L, Ansari D, Swanling M, Holka P, Andersson R. Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer. Ann Gastroenterol 2018;31:115-20. [PMID: 29333076 DOI: 10.20524/aog.2017.0205] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D'Angelica MI, Aloia TA, Eastwood D, Gamblin TC. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis. Ann Surg Oncol 2021;28:1457-65. [PMID: 33393036 DOI: 10.1245/s10434-020-09459-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Sandhu L, Fox A, Nhan C, Barnett H, McLeod RS, Gallinger S, Moulton CA. Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario? HPB (Oxford) 2012;14:409-13. [PMID: 22568418 DOI: 10.1111/j.1477-2574.2012.00467.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
48 Jones C, Badger SA, McClements J, McKie L, Diamond T, Taylor MA. Can the National Health Service Cancer Plan timeline be applied to colorectal hepatic metastases? Ann R Coll Surg Engl 2010;92:136-8. [PMID: 20353641 DOI: 10.1308/003588410X12628812458734] [Reference Citation Analysis]
49 Lordan JT, Riga A, Worthington TR, Karanjia ND. Early and long-term outcomes of patients undergoing liver resection and diaphragm excision for advanced colorectal liver metastases. Ann R Coll Surg Engl 2009;91:483-8. [PMID: 19558763 DOI: 10.1308/003588409x432176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
50 Le DM, Ahmed S, Ahmed S, Brunet B, Davies J, Doll C, Ferguson M, Ginther N, Gordon V, Hamilton T, Hebbard P, Helewa R, Kim CA, Lee-Ying R, Lim H, Loree JM, McGhie JP, Mulder K, Park J, Renouf D, Wong RPW, Zaidi A, Asif T. Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018. Curr Oncol 2019;26:e773-84. [PMID: 31896948 DOI: 10.3747/co.26.5517] [Reference Citation Analysis]
51 Hamidou Z, Chibaudel B, Hebbar M, Hug de Larauze M, André T, Louvet C, Brusquant D, Garcia-Larnicol ML, de Gramont A, Bonnetain F. Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial. PLoS One 2016;11:e0157067. [PMID: 27310205 DOI: 10.1371/journal.pone.0157067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
52 Scorsetti M, Franceschini D, De Rose F, Comito T, Franzese C, Masci G, Torrisi R, Viganò L, Torzilli G. The role of SBRT in oligometastatic patients with liver metastases from breast cancer. Rep Pract Oncol Radiother 2017;22:163-9. [PMID: 28490988 DOI: 10.1016/j.rpor.2016.07.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
53 Kim M, Son SH, Won YK, Kay CS. Stereotactic ablative radiotherapy for oligometastatic disease in liver. Biomed Res Int 2014;2014:340478. [PMID: 24868526 DOI: 10.1155/2014/340478] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
54 Rong Z, Martel G, Vandenbroucke-Menu F, Adam R, Lapointe R. Impact of peri-operative bevacizumab on survival in patients with resected colorectal liver metastases: an analysis of the LiverMetSurvey. HPB (Oxford) 2014;16:342-9. [PMID: 24641317 DOI: 10.1111/hpb.12138] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
55 Hoffmann RT. [Liver metastases of colorectal cancer]. Radiologe 2017;57:90-6. [PMID: 28130578 DOI: 10.1007/s00117-017-0208-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
56 Yang S, Hongjinda S, Hanna SS, Gallinger S, Wei AC, Kiss A, Law C. Utility of preoperative imaging in evaluating colorectal liver metastases declines over time. HPB (Oxford) 2010;12:605-9. [PMID: 20961368 DOI: 10.1111/j.1477-2574.2010.00202.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
57 Lan YT, Jiang JK, Chang SC, Yang SH, Lin CC, Lin HH, Wang HS, Chen WS, Lin TC, Lin JK. Improved outcomes of colorectal cancer patients with liver metastases in the era of the multidisciplinary teams. Int J Colorectal Dis. 2016;31:403-411. [PMID: 26662193 DOI: 10.1007/s00384-015-2459-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
58 Tiernan J, Briggs CD, Irving GR, Swinscoe MT, Peterson M, Cameron IC. Evaluation of the introduction of a standardised protocol for the staging and follow-up of colorectal cancer on resection rates for liver metastases. Ann R Coll Surg Engl 2010;92:225-30. [PMID: 20223052 DOI: 10.1308/003588410X12628812458419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
59 Scorsetti M, Clerici E, Comito T. Stereotactic body radiation therapy for liver metastases. J Gastrointest Oncol 2014;5:190-7. [PMID: 24982767 DOI: 10.3978/j.issn.2078-6891.2014.039] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
60 Jayme VR, Fonseca GM, Amaral IMA, Coelho FF, Kruger JAP, Jeismann VB, Pinheiro RSN, de Mello ES, Herman P. Infiltrative Tumor Borders in Colorectal Liver Metastasis: Should We Enlarge Margin Size? Ann Surg Oncol 2021. [PMID: 33834322 DOI: 10.1245/s10434-021-09916-w] [Reference Citation Analysis]
61 Gorgen A, Muaddi H, Zhang W, McGilvray I, Gallinger S, Sapisochin G. The New Era of Transplant Oncology: Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases. Can J Gastroenterol Hepatol. 2018;2018:9531925. [PMID: 29623268 DOI: 10.1155/2018/9531925] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
62 Kong VC, Velec M. Stereotactic Body Radiation Therapy for Liver Cancer: A Review of the Technology. J Med Imaging Radiat Sci 2015;46:343-50. [PMID: 31052142 DOI: 10.1016/j.jmir.2015.06.005] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
63 Blackham AU, Russell GB, Stewart JH, Votanopoulos K, Levine EA, Shen P. Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21:2667-2674. [PMID: 24615177 DOI: 10.1245/s10434-014-3563-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
64 Roelands J, Kuppen PJK, Vermeulen L, Maccalli C, Decock J, Wang E, Marincola FM, Bedognetti D, Hendrickx W. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications. Int J Mol Sci 2017;18:E2229. [PMID: 29064420 DOI: 10.3390/ijms18102229] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 12.0] [Reference Citation Analysis]
65 Egeland C, Rostved AA, Schultz NA, Pommergaard HC, Daugaard TR, Thøfner LB, Rasmussen A, Hillingsø JG. Morbidity and mortality after liver surgery for colorectal liver metastases: a cohort study in a high-volume fast-track programme. BMC Surg 2021;21:312. [PMID: 34261457 DOI: 10.1186/s12893-021-01301-4] [Reference Citation Analysis]
66 Debbi K, Janoray G, Scher N, Deutsch É, Mornex F. [Doses to organs at risk in conformational and stereotactic body radiation therapy: Liver]. Cancer Radiother 2017;21:604-12. [PMID: 28893525 DOI: 10.1016/j.canrad.2017.07.042] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
67 Campanati RG, Sancio JB, Sucena LMA, Sanches MD, Resende V. PRIMARY TUMOR LYMPHOVASCULAR INVASION NEGATIVELY AFFECTS SURVIVAL AFTER COLORECTAL LIVER METASTASIS RESECTION? Arq Bras Cir Dig 2021;34:e1578. [PMID: 34133525 DOI: 10.1590/0102-672020210001e1578] [Reference Citation Analysis]
68 Wang N, Fallavollita L, Nguyen L, Burnier J, Rafei M, Galipeau J, Yakar S, Brodt P. Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases. Mol Ther 2009;17:1241-9. [PMID: 19367255 DOI: 10.1038/mt.2009.82] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
69 Lo SS, Moffatt-bruce SD, Dawson LA, Schwarz RE, Teh BS, Mayr NA, Lu JJ, Grecula JC, Olencki TE, Timmerman RD. The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 2011;8:405-16. [DOI: 10.1038/nrclinonc.2011.75] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 7.2] [Reference Citation Analysis]
70 Stein A, Glockzin G, Wienke A, Arnold D, Edelmann T, Hildebrandt B, Hollerbach S, Illerhaus G, Königsrainer A, Richter M, Schlitt HJ, Schmoll HJ. Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature. BMC Cancer 2012;12:356. [PMID: 22897915 DOI: 10.1186/1471-2407-12-356] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
71 Berber B, Ibarra R, Snyder L, Yao M, Fabien J, Milano MT, Katz AW, Goodman K, Stephans K, El-Gazzaz G, Aucejo F, Miller C, Fung J, Lo S, Machtay M, Sanabria J. Multicentre results of stereotactic body radiotherapy for secondary liver tumours. HPB (Oxford) 2013;15:851-7. [PMID: 23458468 DOI: 10.1111/hpb.12044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
72 Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN; Americas Hepato-Pancreato-Biliary Association; Society of Surgical Oncology; Society for Surgery of the Alimentary Tract. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15:91-103. [PMID: 23297719 DOI: 10.1111/j.1477-2574.2012.00557.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 155] [Article Influence: 20.0] [Reference Citation Analysis]
73 Rusthoven CG, Schefter TE. Rationale for ablation of oligometastatic disease and the role of stereotactic body radiation therapy for hepatic metastases. Hepat Oncol 2014;1:81-94. [PMID: 30190943 DOI: 10.2217/hep.13.12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
74 Kow AWC. Hepatic metastasis from colorectal cancer. J Gastrointest Oncol 2019;10:1274-98. [PMID: 31949948 DOI: 10.21037/jgo.2019.08.06] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
75 Verbeek FP, van der Vorst JR, Schaafsma BE, Hutteman M, Bonsing BA, van Leeuwen FW, Frangioni JV, van de Velde CJ, Swijnenburg RJ, Vahrmeijer AL. Image-guided hepatopancreatobiliary surgery using near-infrared fluorescent light. J Hepatobiliary Pancreat Sci 2012;19:626-37. [PMID: 22790312 DOI: 10.1007/s00534-012-0534-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
76 Blackham AU, Swett K, Levine EA, Shen P. Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience. Colorectal Cancer 2013;2:73-88. [PMID: 25110522 DOI: 10.2217/crc.12.80] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
77 Haddad AJ, Bani Hani M, Pawlik TM, Cunningham SC. Colorectal liver metastases. Int J Surg Oncol 2011;2011:285840. [PMID: 22312501 DOI: 10.1155/2011/285840] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
78 Coffman AR, Sufficool DC, Kang JI, Hsueh CT, Swenson S, McGee PQ, Nagaraj G, Patyal B, Reeves ME, Slater JD, Yang GY. Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesions. J Gastrointest Oncol 2021;12:1753-60. [PMID: 34532125 DOI: 10.21037/jgo-20-424] [Reference Citation Analysis]
79 van der Vorst JR, Hutteman M, Mieog JS, de Rooij KE, Kaijzel EL, Löwik CW, Putter H, Kuppen PJ, Frangioni JV, van de Velde CJ, Vahrmeijer AL. Near-infrared fluorescence imaging of liver metastases in rats using indocyanine green. J Surg Res 2012;174:266-71. [PMID: 21396660 DOI: 10.1016/j.jss.2011.01.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
80 Ahmed S, Johnson K, Ahmed O, Iqbal N. Advances in the management of colorectal cancer: from biology to treatment. Int J Colorectal Dis 2014;29:1031-42. [PMID: 24953060 DOI: 10.1007/s00384-014-1928-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
81 Hackl C, Gerken M, Loss M, Klinkhammer-schalke M, Piso P, Schlitt HJ. A population-based analysis on the rate and surgical management of colorectal liver metastases in Southern Germany. Int J Colorectal Dis 2011;26:1475-81. [DOI: 10.1007/s00384-011-1278-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
82 Vatandoust S, Price TJ, Karapetis CS. Colorectal cancer: Metastases to a single organ. World J Gastroenterol 2015; 21(41): 11767-11776 [PMID: 26557001 DOI: 10.3748/wjg.v21.i41.11767] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 100] [Article Influence: 16.0] [Reference Citation Analysis]
83 Hua D, Sun J, Mao Y, Chen LJ, Wu YY, Zhang XG. B7-H1 expression is associated with expansion of regulatory T cells in colorectal carcinoma. World J Gastroenterol 2012; 18(9): 971-978 [PMID: 22408358 DOI: 10.3748/wjg.v18.i9.971] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
84 Sato H, Maeda K, Morise Z, Takahashi H, Sugihara K; Japanese Study Group for Postoperative Follow-up of Colorectal Cancer. Clinical outcomes of stage IV colorectal cancer after R0 resection: a multi-institutional retrospective analysis. Int J Clin Oncol 2017;22:297-306. [PMID: 27714536 DOI: 10.1007/s10147-016-1043-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Kron P, Linecker M, Jones RP, Toogood GJ, Clavien PA, Lodge JPA. Ablation or Resection for Colorectal Liver Metastases? A Systematic Review of the Literature. Front Oncol. 2019;9:1052. [PMID: 31750233 DOI: 10.3389/fonc.2019.01052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
86 Kim WW, Kim KH, Kim SH, Kim JS, Park SJ, Kim KH, Choi CS, Choi YK. Comparison of Hepatic Resection and Radiofrequency Ablation for the Treatment of Colorectal Liver Metastasis. Indian J Surg 2015;77:1126-30. [PMID: 27011523 DOI: 10.1007/s12262-015-1211-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
87 Akyuz M, Aucejo F, Quintini C, Miller C, Fung J, Berber E. Factors affecting surgical margin recurrence after hepatectomy for colorectal liver metastases. Gland Surg 2016;5:263-9. [PMID: 27294032 DOI: 10.21037/gs.2015.12.03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
88 Suzuki K, Muto Y, Ichida K, Fukui T, Takayama Y, Kakizawa N, Kato T, Hasegawa F, Watanabe F, Kaneda Y, Kikukawa R, Saito M, Tsujinaka S, Futsuhara K, Takata O, Noda H, Miyakura Y, Kiyozaki H, Konishi F, Rikiyama T. Morphological response contributes to patient selection for rescue liver resection in chemotherapy patients with initially un-resectable colorectal liver metastasis. Oncol Lett. 2017;14:1491-1499. [PMID: 28789370 DOI: 10.3892/ol.2017.6338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
89 Fernandez MC, Rayes R, Ham B, Wang N, Bourdeau F, Milette S, Lllemann M, Bird N, Majeed A, Xu J, Kisselova T, Brodt P. The type I insulin-like growth factor regulates the liver stromal response to metastatic colon carcinoma cells. Oncotarget 2017;8:52281-93. [PMID: 28881729 DOI: 10.18632/oncotarget.12595] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
90 Abbas S, Lam V, Hollands M. Ten-year survival after liver resection for colorectal metastases: systematic review and meta-analysis. ISRN Oncol. 2011;2011:763245. [PMID: 22091431 DOI: 10.5402/2011/763245] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
91 Achiam MP, Løgager VB, Skjoldbye B, Møller JM, Lorenzen T, Rasmussen VL, Thomsen HS, Mollerup TH, Okholm C, Rosenberg J. Preoperative CT versus diffusion weighted magnetic resonance imaging of the liver in patients with rectal cancer; a prospective randomized trial. PeerJ 2016;4:e1532. [PMID: 26793420 DOI: 10.7717/peerj.1532] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
92 Reddy SK, Broadwater G, Niedzwiecki D, Barbas AS, Hurwitz HI, Bendell JC, Morse MA, Clary BM. Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study. J Gastrointest Surg 2009;13:74-84. [PMID: 18685900 DOI: 10.1007/s11605-008-0617-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
93 Lyratzopoulos G, Tyrrell C, Smith P, Yelloly J. Recent trends in liver resection surgery activity and population utilization rates in English regions. HPB (Oxford) 2007;9:277-80. [PMID: 18345304 DOI: 10.1080/13651820701504165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
94 Deutsch GB, Flaherty DC, Kirchoff DD, Bailey M, Vitug S, Foshag LJ, Faries MB, Bilchik AJ. Association of Surgical Treatment, Systemic Therapy, and Survival in Patients With Abdominal Visceral Melanoma Metastases, 1965-2014: Relevance of Surgical Cure in the Era of Modern Systemic Therapy. JAMA Surg 2017;152:672-8. [PMID: 28384791 DOI: 10.1001/jamasurg.2017.0459] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 7.2] [Reference Citation Analysis]
95 Malde DJ, Khan A, Prasad KR, Toogood GJ, Lodge JP. Inferior vena cava resection with hepatectomy: challenging but justified. HPB (Oxford). 2011;13:802-810. [PMID: 21999594 DOI: 10.1111/j.1477-2574.2011.00364.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
96 Van Tilborg AA, Meijerink MR, Sietses C, Van Waesberghe JH, Mackintosh MO, Meijer S, Van Kuijk C, Van Den Tol P. Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br J Radiol. 2011;84:556-565. [PMID: 21159807 DOI: 10.1259/bjr/78268814] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
97 Mertens J, De Bruyne S, Van Damme N, Smeets P, Ceelen W, Troisi R, Laurent S, Geboes K, Peeters M, Goethals I, Van de Wiele C. Standardized added metabolic activity (SAM) IN ¹⁸F-FDG PET assessment of treatment response in colorectal liver metastases. Eur J Nucl Med Mol Imaging 2013;40:1214-22. [PMID: 23636802 DOI: 10.1007/s00259-013-2421-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
98 Soda H, Maeda H, Hasegawa J, Takahashi T, Hazama S, Fukunaga M, Kono E, Kotaka M, Sakamoto J, Nagata N, Oba K, Mishima H. Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study. BMC Cancer. 2015;15:695. [PMID: 26467662 DOI: 10.1186/s12885-015-1685-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
99 Dawson LA, Winter KA, Katz AW, Schell MC, Brierley J, Chen Y, Kopek N, Crane CH, Willett CG. NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases. Pract Radiat Oncol 2019;9:e386-93. [PMID: 30825666 DOI: 10.1016/j.prro.2019.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
100 Ma XT, Yu LW, Zhang ZX, Wang S, Du RY, Cui ZR. Role of chemokine receptor CXCR4/CXCL12 signaling pathway in hepatic metastasis of colorectal carcinoma. Shijie Huaren Xiaohua Zazhi 2006; 14(16): 1566-1570 [DOI: 10.11569/wcjd.v14.i16.1566] [Cited by in CrossRef: 2] [Article Influence: 0.1] [Reference Citation Analysis]
101 Nielsen K, van Tilborg AA, Meijerink MR, Macintosh MO, Zonderhuis BM, de Lange ES, Comans EF, Meijer S, van den Tol MP. Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg 2013;37:1340-7. [PMID: 23494086 DOI: 10.1007/s00268-013-1997-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
102 Sager O, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Dirican B, Beyzadeoglu M. A Concise Review of Pelvic Radiation Therapy (RT) for Rectal Cancer with Synchronous Liver Metastases. Int J Surg Oncol 2019;2019:5239042. [PMID: 31139467 DOI: 10.1155/2019/5239042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
103 Fonseca AL, Payne IC, Wong SL, Tan MCB. Surgical Resection of Colorectal Liver Metastases: Attitudes and Practice Patterns in the Deep South. J Gastrointest Surg 2021. [PMID: 34647225 DOI: 10.1007/s11605-021-05159-y] [Reference Citation Analysis]